Dr. Amy Abernethy, Principal Deputy Commissioner of the United States Food and Drug Administration (FDA), reveals that her office is looking into ways of incorporating blockchain technology in the review methodology for medical products.  According to Dr. Abernethy, the FDA is actively looking to modernize and streamline the communication channels between manufacturers, suppliers, and the […]